Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Ursodeoxycholic Acid (600mg) SR
Therapeutic Category
Hepatology, Urology
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
10*10
Price
₹799/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Udostep 600 SR Tablet containing Ursodeoxycholic Acid is used for supporting liver health and managing gallstone-related and bile flow disorders. It helps improve bile movement and protect liver function.
Ursodeoxycholic Acid works by reducing cholesterol content in bile and improving bile flow, helping dissolve certain gallstones and supporting healthy liver functioning.
The sustained-release formulation provides prolonged therapeutic action, making it suitable for long-term liver and hepatobiliary care management with consistent clinical demand.
With increasing prevalence of fatty liver disorders, gallbladder conditions, and lifestyle-related liver issues, this product offers strong business potential for retailers and distributors. Its chronic therapy usage, hepatology relevance, and steady prescription demand make it a reliable product for growth in the liver care segment.
Possible side effects include nausea, diarrhea, abdominal pain, and headache. In rare cases, allergic reactions or liver enzyme abnormalities may occur.
Udostep 600 SR is indicated for the treatment of liver conditions such as primary biliary cirrhosis, gallstones, and intrahepatic cholestasis. It also helps improve liver function and reduce liver damage caused by various hepatobiliary diseases.
Consult a doctor before using this medication, especially in patients with a history of liver disease or gallbladder disorders.
Store in a cool, dry place away from direct sunlight. Keep out of reach of children.
Composition : Ursodeoxycholic Acid (150mg)
Composition : Ursodeoxycholic Acid (300mg)
Composition : Ursodeoxycholic Acid (450mg) SR
Composition : Ursodeoxycholic Acid (125mg/5ml)
Composition : Sodium Bicarbonate (500mg)
Composition : Sodium Bicarbonate (1000mg)
Composition : Obeticholic acid (5mg) Tablet
Composition : Obeticholic acid (10mg) Tablet
Composition : Rabeprazole (20mg)
Composition : Lansoprazole (30mg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Udostep 600 SR Tablet has growing demand in the liver care and gastroenterology segment, making it a profitable product for medical distributors, wholesalers, and pharma franchise partners looking to expand their presence in the PCD pharma franchise market.
Medical distributors and wholesalers can benefit from the consistent market demand for Udostep 600 SR Tablet in hepatology and digestive healthcare segments. Including this product helps strengthen their liver care and specialty medicine portfolio.
Yes, Cafoli Lifecare offers PCD pharma franchise opportunities for Udostep 600 SR Tablet with monopoly rights, promotional support, quality packaging, competitive pricing, and reliable product availability for distributors and medical agencies.
Wholesalers and medical agencies benefit from attractive business margins, timely product supply, professional marketing support, and access to a trusted liver care pharmaceutical range when partnering with Cafoli Lifecare for Udostep 600 SR Tablet distribution.
Medical distributors, stockists, wholesalers, and pharma professionals interested in Udostep 600 SR Tablet can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, bulk supply requirements, pricing details, and distribution support services.